PharmaEngine (Taiwan) Performance
| 4162 Stock | TWD 94.00 0.20 0.21% |
PharmaEngine has a performance score of 5 on a scale of 0 to 100. The company holds a Beta of -0.17, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PharmaEngine are expected to decrease at a much lower rate. During the bear market, PharmaEngine is likely to outperform the market. PharmaEngine right now holds a risk of 2.32%. Please check PharmaEngine market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to decide if PharmaEngine will be following its historical price patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in PharmaEngine are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, PharmaEngine may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 1.8 B | |
| Total Cashflows From Investing Activities | -107 M |
PharmaEngine |
PharmaEngine Relative Risk vs. Return Landscape
If you would invest 8,630 in PharmaEngine on August 29, 2024 and sell it today you would earn a total of 770.00 from holding PharmaEngine or generate 8.92% return on investment over 90 days. PharmaEngine is generating 0.1619% of daily returns and assumes 2.3181% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than PharmaEngine, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
PharmaEngine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PharmaEngine's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PharmaEngine, and traders can use it to determine the average amount a PharmaEngine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0698
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 4162 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.32 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average PharmaEngine is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PharmaEngine by adding it to a well-diversified portfolio.
PharmaEngine Fundamentals Growth
PharmaEngine Stock prices reflect investors' perceptions of the future prospects and financial health of PharmaEngine, and PharmaEngine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PharmaEngine Stock performance.
| Return On Equity | 0.0985 | |||
| Return On Asset | 0.0589 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.53 % | |||
| Current Valuation | 14.42 B | |||
| Shares Outstanding | 143.69 M | |||
| Price To Book | 4.72 X | |||
| Price To Sales | 24.13 X | |||
| Revenue | 654.84 M | |||
| EBITDA | 555.87 M | |||
| Book Value Per Share | 26.57 X | |||
| Cash Flow From Operations | 929.67 M | |||
| Earnings Per Share | 2.62 X | |||
| Total Asset | 4.03 B | |||
About PharmaEngine Performance
Evaluating PharmaEngine's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if PharmaEngine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PharmaEngine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about PharmaEngine performance evaluation
Checking the ongoing alerts about PharmaEngine for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PharmaEngine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 23.0% of the company shares are owned by insiders or employees |
- Analyzing PharmaEngine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PharmaEngine's stock is overvalued or undervalued compared to its peers.
- Examining PharmaEngine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PharmaEngine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PharmaEngine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PharmaEngine's stock. These opinions can provide insight into PharmaEngine's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PharmaEngine Stock Analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.